mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.6 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.6 |